[Federal Register Volume 62, Number 173 (Monday, September 8, 1997)]
[Notices]
[Page 47212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-23728]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: National Mammography Quality Assurance Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on October 28, 1997, 9 a.m. 
to 5 p.m., and October 29, 1997, 8 a.m. to 5 p.m.
    Location: Sheraton Premiere Hotel at Tysons Corner, conference room 
6, 8661 Leesburg Pike, Vienna, VA.
    Contact Person: Charles A. Finder, Center for Devices and 
Radiological Health (HFZ-240), Food and Drug Administration, 1350 
Piccard Dr., Rockville, MD 20850, 301-594-3332, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12397. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: On October 28 and 29, 1997, the committee will discuss 
regulation of interventional mammography under the Mammography Quality 
Standards Act of 1992.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by September 26, 
1997. Oral presentations from the public will be scheduled between 
approximately 9:30 a.m. and 10:30 a.m. on October 28, 1997. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before 
September 26, 1997, and submit a brief statement of the general nature 
of the evidence or arguments they wish to present, the names and 
addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: September 3, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-23728 Filed 9-5-97; 8:45 am]
BILLING CODE 4160-01-F